Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS50+3A>G (c.6313+3A>G) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAG | Glu | spl+3 | Spl. | A->G | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
TGFBP#06 |
At the mRNA level | On restriction map |
Not tested on cDNA | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
ATGgtatgt |
| ATGgtgtgt |
| -12.5 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
GER01BER F0048 I79 | Proband | Male | de novo | 13 years old | GERMANY |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Incomplete description |
S-Pectus carinatum (M)(2) |
S-Reduced US/LS ratio <0.87 (M) |
Reference ID | PubMed ID | Reference |
95 | 12203992 | Katzke S, Booms P, Tiecke F, Palz M, Pletschacher A, Turkmen S, Neumann LM, Pregla R, Leitner C, Schramm C, Lorenz P, Hagemeier C, Fuchs J, Skovby F, Rosenberg T, Robinson PN. "TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies". Hum Mutat. 2002 Sep;20(3):197-208. |